| Product Code: ETC11489406 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Cannabis Pharmaceuticals Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Cannabis Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Cannabis Pharmaceuticals Market - Industry Life Cycle |
3.4 Austria Cannabis Pharmaceuticals Market - Porter's Five Forces |
3.5 Austria Cannabis Pharmaceuticals Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Austria Cannabis Pharmaceuticals Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Austria Cannabis Pharmaceuticals Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Austria Cannabis Pharmaceuticals Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Austria Cannabis Pharmaceuticals Market Revenues & Volume Share, By Benefit, 2021 & 2031F |
4 Austria Cannabis Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance of medical cannabis for various health conditions in Austria |
4.2.2 Growing awareness about the therapeutic benefits of cannabis pharmaceuticals |
4.2.3 Favorable government regulations supporting the use of medical cannabis in Austria |
4.3 Market Restraints |
4.3.1 Limited availability of medical cannabis products in the Austrian market |
4.3.2 High production costs associated with cannabis pharmaceuticals |
4.3.3 Stringent regulatory requirements for the manufacturing and distribution of cannabis pharmaceuticals in Austria |
5 Austria Cannabis Pharmaceuticals Market Trends |
6 Austria Cannabis Pharmaceuticals Market, By Types |
6.1 Austria Cannabis Pharmaceuticals Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.4 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Oils, 2021 - 2031F |
6.1.5 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Topicals, 2021 - 2031F |
6.2 Austria Cannabis Pharmaceuticals Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Pain Management, 2021 - 2031F |
6.2.3 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Anxiety Relief, 2021 - 2031F |
6.2.4 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Skin Conditions, 2021 - 2031F |
6.3 Austria Cannabis Pharmaceuticals Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Patients, 2021 - 2031F |
6.3.3 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Austria Cannabis Pharmaceuticals Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Cannabis-Based, 2021 - 2031F |
6.4.3 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Hemp-Based, 2021 - 2031F |
6.4.4 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Plant-Based, 2021 - 2031F |
6.5 Austria Cannabis Pharmaceuticals Market, By Benefit |
6.5.1 Overview and Analysis |
6.5.2 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Non-Psychoactive, 2021 - 2031F |
6.5.3 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Natural, 2021 - 2031F |
6.5.4 Austria Cannabis Pharmaceuticals Market Revenues & Volume, By Anti-Inflammatory, 2021 - 2031F |
7 Austria Cannabis Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Austria Cannabis Pharmaceuticals Market Export to Major Countries |
7.2 Austria Cannabis Pharmaceuticals Market Imports from Major Countries |
8 Austria Cannabis Pharmaceuticals Market Key Performance Indicators |
8.1 Number of medical professionals prescribing cannabis pharmaceuticals in Austria |
8.2 Research and development investments in cannabis pharmaceuticals by companies operating in Austria |
8.3 Patient enrollment in medical cannabis programs in Austria |
9 Austria Cannabis Pharmaceuticals Market - Opportunity Assessment |
9.1 Austria Cannabis Pharmaceuticals Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Austria Cannabis Pharmaceuticals Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Austria Cannabis Pharmaceuticals Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Austria Cannabis Pharmaceuticals Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Austria Cannabis Pharmaceuticals Market Opportunity Assessment, By Benefit, 2021 & 2031F |
10 Austria Cannabis Pharmaceuticals Market - Competitive Landscape |
10.1 Austria Cannabis Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 Austria Cannabis Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here